Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Genetic Engineering?00:49

What is Genetic Engineering?

80.9K
Overview
80.9K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Transgenic Organisms00:53

Transgenic Organisms

34.1K
Overview
34.1K
Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

17.5K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
17.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies - A stakeholder meeting report.

Biologicals : journal of the International Association of Biological Standardization·2025
Same author

The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access.

The Lancet. Infectious diseases·2024
Same author

The pharmaceutical productivity gap - Incremental decline in R&D efficiency despite transient improvements.

Drug discovery today·2024
Same author

An Innovative AI-based primer design tool for precise and accurate detection of SARS-CoV-2 variants of concern.

Scientific reports·2023
Same author

ESWI pandemic preparedness summit: where science and policy meet : Tuesday 21 June 2022, Brussels and online.

One health outlook·2023
Same author

Cross-reactive immunity potentially drives global oscillation and opposed alternation patterns of seasonal influenza A viruses.

Scientific reports·2022

Related Experiment Video

Updated: Mar 9, 2026

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

11.9K

Vector-based genetically modified vaccines: Exploiting Jenner's legacy.

Bahar Ramezanpour1, Ingrid Haan1, Ab Osterhaus2

  • 1Vrije Universiteit Amsterdam, Earth & Life Sciences, Athena Institute, De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands.

Vaccine
|December 29, 2016
PubMed
Summary

Genetic modification (GM) vaccine technology shows promise, with vector-based vaccines like those using poxviruses and adenoviruses leading development. This approach may yield new vaccines for unmet medical needs.

Keywords:
Genetically modified techniquesGenetically modifies vaccinesNovel vaccine platformsPoxviruses and adenovirusesVector-based vaccinesVectors

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.3K
Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing
12:21

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing

Published on: January 7, 2019

14.3K

Related Experiment Videos

Last Updated: Mar 9, 2026

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

11.9K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.3K
Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing
12:21

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing

Published on: January 7, 2019

14.3K

Area of Science:

  • Vaccinology
  • Genetic Engineering
  • Infectious Disease Research

Background:

  • The global vaccine market is rapidly evolving, with genetic modification (GM) techniques offering potential for advanced vaccine design.
  • Despite advancements, effective vaccines for major diseases like AIDS, malaria, and neoplastic disorders remain unavailable.
  • Current market penetration of GM technology in newly introduced vaccines is limited.

Purpose of the Study:

  • To explore the field of vector-based genetically modified (GM) vaccines.
  • To provide an overview of vector-based technology in GM vaccine development by analyzing available and emerging data.
  • To assess the contribution of vector technology to the GM vaccine pipeline.

Main Methods:

  • Data retrieval from diverse sources on existing, applied, and novel vaccine vectors.
  • Synthesis and analysis of retrieved data on vector-based GM vaccines.
  • Review of patenting, preclinical, and clinical research activities.

Main Results:

  • Vector-based vaccines constitute a significant portion of the GM vaccine pipeline.
  • Poxviruses and adenoviruses are identified as prominent vectors in GM vaccine development.
  • Despite only two vector-based vaccines on the market, extensive research is ongoing.

Conclusions:

  • Vector-based vaccine technology, particularly using poxviruses and adenoviruses, holds significant promise for future vaccine development.
  • This technology could enable cost-effective production of safe vaccines for diseases with unmet needs.
  • Viral vectors, building on historical vaccine successes, may offer solutions for major global health challenges.